Pasithea Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2020-01-01
- Employees
- 8
- Market Cap
- -
- Website
- http://www.pasithea.com
- Introduction
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Phase 1
Not yet recruiting
- Conditions
- NF1 MutationNeurofibroma, PlexiformNeurofibroma PlexiformNeurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)Neurofibromatosis Type 1 (NF1)
- Interventions
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Pasithea Therapeutics Corp.
- Target Recruit Count
- 56
- Registration Number
- NCT06961565
- Locations
- 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
PAS-004 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- RAS MutationNF1 MutationRAF MutationAdvanced Solid Tumors
- Interventions
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Pasithea Therapeutics Corp.
- Target Recruit Count
- 48
- Registration Number
- NCT06299839
- Locations
- 🇷🇴
Institute of Oncology Bucharest Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania
🇷🇴Institute of Oncology Prof. Dr. Ion Chiricuta, Cluj-Napoca, Romania
🇺🇸NEXT Oncology, Fairfax, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath